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Introduction
============

Cardiovascular disease is the leading cause of death and disability worldwide. About 80% of deaths from cardiovascular disease occur in developing countries.[@ref1] Raised blood pressure is a major cause of such disease, accounting for 62% of strokes and 49% of cases of ischaemic heart disease.[@ref2] Dietary salt intake is the main factor that increases blood pressure and is largely responsible for the rise in blood pressure with age.[@ref3] [@ref4] There is compelling evidence in adults that a modest reduction in salt intake lowers blood pressure and reduces the risk of cardiovascular disease.[@ref4] [@ref5] [@ref6] [@ref7] [@ref8] Indeed, salt reduction is one of the most cost effective measures to prevent cardiovascular disease in both developed and developing countries.[@ref9] [@ref10] [@ref11] The World Health Organization has recommended salt reduction as one of the top three priority actions to tackle the global crisis in non-communicable disease.[@ref12] [@ref13]

Although raised blood pressure and cardiovascular disease typically present in adults, the origins begin in childhood.[@ref14] [@ref15] Accordingly, the greatest long term potential to reduce these conditions is to initiate prevention activities in young people. Such a public heath strategy aimed at preventing or slowing the progression of rising blood pressure altogether would have enormous benefits. Several lines of evidence from animal experiments, epidemiological studies, and controlled trials have shown that salt intake plays an important role in regulating blood pressure in children.[@ref16] A lower salt diet starting from childhood could lessen the rise in blood pressure with age and therefore help to prevent the development of high blood pressure and cardiovascular disease later in life.

China is the largest developing country in the world. Raised blood pressure caused by excessive salt consumption is highly prevalent.[@ref17] The problem is particularly marked in northern China, where salt intake is high in both adults[@ref18] and children. Unlike in developed countries, the major source of salt in the Chinese diet is salt added by the consumers themselves during food preparation.[@ref19] [@ref20] An important strategy to reduce population salt intake would be to encourage the general public to reduce the amount of salt used at home. To date, no country has demonstrated a successful programme where salt intake has fallen because consumers have been educated to use less salt. Indeed, it is difficult to persuade individuals to change their diet.

The School-EduSalt (School-based Education Programme to Reduce Salt) study aimed to develop a novel approach to lowering salt intake. In China, children have a big influence on the family. Our approach was to educate primary school children about the harmful effects of excessive salt intake and to empower them to educate their families to reduce the amount of salt used at home. We hypothesised that such an education programme could lower salt intake in both children and their families. To test this hypothesis, we carried out a cluster randomised controlled trial in Changzhi, northern China.

Methods
=======

A detailed description of the methods of the School-EduSalt study has been published elsewhere.[@ref21]

Study design and participants
-----------------------------

The study was a cluster randomised controlled trial. Primary schools in urban Changzhi were eligible. We excluded schools in rural areas to avoid contamination from school meals as some children in such schools have lunch and dinner at school because of the long distance from home, whereas in urban schools most children have lunch and dinner at home.

There are 36 primary schools in urban Changzhi. We excluded eight schools: three special Muslim schools, two schools that were far from the study centre, and three schools with headteachers who were not willing to participate. The 28 remaining schools were included.

In primary schools in Changzhi, there are six grades for children aged 7-12. Our study was carried out in grade 5 children (age about 10) only. From each school, we selected one class (if there was more than one) in grade 5. With the headteacher we selected a class whose teacher in charge was willing to collaborate with the researchers.

We used a random number list (created by a researcher who was blind to the identity of the participants) to randomly select children from each class until 10 children were recruited. To be eligible for inclusion in the assessments, children had to eat homemade meals at least three days a week and live not too far from the school (\<3 km). In two schools where the class had fewer than 15 children, we invited all children to take part in the assessments.

From each child's family we invited two adults for assessments. All adults who shared the same meals with the child were eligible. If more than two adults in one family were willing to participate, we selected two of them (one man and one woman) in the order of grandparents, parents, uncles, and aunts.

Randomisation
-------------

Schools (clusters) were randomly assigned (1:1) to either the intervention or the control group. Randomisation was stratified by the location of schools (urban or suburban) and the size of the class. Among all schools in urban Changzhi, the size of the class varied from 14 to 75 children a class. Usually, a larger class size indicates that the school is at the upper level of the league table in terms of exam results.

An independent statistician who was blind to the identity of the schools carried out the randomisation using a computer generated random number system. The randomisation took place after written consents had been obtained and the baseline assessments had completed. The participants, the schoolteachers, and the local investigators who undertook participant recruitment and data collection were therefore unaware of the allocation until the point before the start of the intervention.

Intervention
------------

Our aim was to reduce salt intake by a minimum of 20%.[@ref21] To achieve this, we set 50% reduction as the target, toward which an intervention strategy was developed and implemented.[@ref21] The intervention duration was one school term (about 3.5 months). Our slogan was "small hands leading big hands, together let's reduce salt." The salt reduction curriculum and materials were developed around the key messages: the harmful effects of salt on health and the salt reduction target; the recommended level of salt intake; and how to reduce salt intake.

Local health educators who were trained by research staff over a four day workshop delivered the salt reduction education programme. A detailed intervention manual and resources were provided. The programme materials consisted of lesson plans, activity worksheets, and homework assignments. The materials were developed around cartoon characters. A detailed description of the education programme is provided in the appendix.

Main components of programme
----------------------------

### Classroom component

For the selected classes, the usual health education lessons (a 40 minute lesson, every two weeks; a total of eight lessons in one school term of about 3.5 months) were replaced with lessons on salt reduction. The lessons were delivered to the whole class, despite only 10 children being selected for assessments. The lessons included three proactive and interactive lectures, one themed class meeting to share experiences, one class meeting for family participation, and three other activities to assist in salt reduction, such as competitions on writing and illustration, plays among children, and salt reduction knowledge involving both children and adults with family as a unit (see appendix). Schoolteachers assisted in the lessons and coordinated all events. Posters on the harmful effects of salt and how to reduce salt intake were put up in the classroom.

Children were asked to complete the following tasks as homework: emphasise the 50% salt reduction target and remind the whole family of this target after each lesson; deliver the salt reduction messages, salt reduction methods, and skilful tips to the whole family; and develop a salt reduction action plan for their own family and supervise the actions at home.

### Family component

Children needed to persuade the people who did the cooking to reduce the amount of salt, soy sauce, and bean paste used. Garlic, ginger, and herbs were recommended for enhancing food flavour. We also recommended replacing pickles with fresh vegetables and replacing salted eggs and peanuts with unsalted ones. We encouraged participants to replace the usual salt with a mineral salt that is low in sodium and high in potassium. No special foods or salt substitutes were provided, and the important message was to reduce the total amount of salt used.

Parents were provided with educational materials in the form of a newsletter (see appendix) that covered topics such as salt and its effect on blood pressure and cardiovascular disease, the major sources of salt in the diet, and cooking with reduced salt. The newsletter also had a question and answer column and a family quiz. Homework set for the students was related to the newsletter.

Monitoring of family use of salt
--------------------------------

As more than 75% of salt in the diet came from salt added during food preparations at home,[@ref19] we estimated the approximate amount of salt used per family and monitored it every two weeks. Each family was provided with a container, and parents were asked to put all of the salt in their household into the container and use salt from this container only. Children brought the salt container to school every two weeks, and the teachers measured the weight. The amount of salt used by the household for those two weeks was calculated with a computer programme that also provided information on how far the family's salt use was different from the target set (that is, 50% reduction). The results were communicated back to the families.

We reported the amount of salt used as grams per person per day (that is, the total amount of salt used by the family divided by the number of family members). Each family was also provided with a salt control spoon (2 g salt). Parents were asked to use this spoon if they thought it was necessary to add salt during cooking as it would help them to estimate the amount used.

Control group
-------------

Children in the control group carried on with their usual health education lessons as in the curriculum, and these lessons did not contain information on salt.

Outcome measures
----------------

Our primary outcome was the difference between the intervention and the control group in the change of salt intake as measured by 24 hour urinary sodium from baseline to the end of the trial. The secondary outcome was the difference between the two groups in the change of blood pressure.

All outcome assessments were carried out at baseline and at the end of the trial in exactly the same way in all schools for all participants, irrespective of their assignment to intervention or control group.

We carried out two consecutive 24 hour urine collections. Trained research staff carefully instructed participants on how to accurately collect 24 hour urine samples. On the first visit to the participants' home, the researchers asked the participants to empty their bladder and discard the urine. The researchers recorded the start time and date of the 24 hour urine collection. They then gave the participants the collection equipment including containers and collection aids such as carrier bags. The participants were instructed to collect all subsequent urine voids over the next 24 hour period. On the second day at the same time, the researchers revisited the participants' home and asked them to pass the last urine into the container. The researchers recorded the finish time of the first 24 hour urine collection. The researchers then gave the participants the collection equipment for the second 24 hour urine collection and repeated the process. Participants were told to take spare urine containers with them when they went to school or work. Spare collection equipment was also available in the schools, in case children forgot to bring containers. For most families, collections were made on the same days of the week for baseline and follow-up. In the event that the participant missed one or more urine voids or spilt \>10% of the total 24 hour urine volume, the participant was asked to do a further 24 hour collection.

The urine samples were measured for volume and sodium, potassium, and creatinine concentrations. An ion selective electrode method was used for sodium and potassium analysis (AC9102 electrolyte analyzer, Audicom Medical Technology, Jiangsu) and Jaffe method for creatinine (Hitachi 7080 automatic biochemical analyzer, Japan). The biochemists who performed the urinary electrolyte measurements were not aware of the participants' group allocation.

We used the average of the two 24 hour urinary measurements at each time point in the analysis. In one child and six adults, however, we had only one 24 hour urine collection at baseline; and in one adult we had only one 24 hour urine collection at follow-up. In these cases, we used one 24 hour urinary measurement.

Trained researchers measured blood pressure and pulse rate at the participants' homes using a validated automatic blood pressure monitor (Omron HEM-7301-IT, Amsterdam) with an appropriately sized cuff. After participants had rested for 10 minutes in a quiet room, three readings were taken in the right arm at two minute intervals with the participants in the sitting position and the arm supported at heart level. We used the average of the last two measurements for the analysis. Body weight and height were measured in participants without shoes or heavy clothes, with a standardised protocol. Both indoor and outdoor temperatures were measured with a thermometer (Anymetre, JR913).

Project timeline
----------------

The baseline assessments were carried out between late May and early July 2013---that is, before the school summer holiday. Randomisation took place during the summer holiday in August. The intervention programme was carried out during the school term from September to December. The follow-up assessments were carried out between late November and December 2013.

Sample size calculation
-----------------------

Based on a pilot study in schoolchildren aged 8-9 in London, in which salt intake measured by 24 hour urinary sodium was about 5 g/day with an SD of 2.15 and intracluster correlation coefficient of 0.01,[@ref22] we estimated that a sample size of 240 children from 24 schools (cluster size 10) would provide 90% power to detect a difference of 20% in salt intake (that is, 1.0 g/day) between the two groups, with α=0.05 and allowing for a 10% dropout rate.[@ref23] To ensure that the study had a sufficient power, we recruited 28 schools with 279 children.

We aimed to recruit two adults per family. We estimated that a sample size of 560 would provide a power of \>95% with α=0.05 to detect a difference of 20% in salt intake (that is, 2 g/day reduction from 10 g/day), assuming an SD of 3.5.[@ref24]

Statistical analysis
--------------------

Our main analysis was based on intention to treat. We tested the effect of the intervention on the outcomes using linear mixed models with participants nested within family units and families nested within school units. We included group (intervention, control), time (baseline, end of trial), and time×group interaction, with the time×group interaction term indicating differential change by group from baseline to the end of the trial. To account for missing data on continuous outcomes, we used the likelihood based random effects model that uses all available data and provides valid estimates of the intervention effects when data are missing at random. We adjusted for the stratification variables at randomisation (school location and class size) and potential confounding variables including age (children=1; adults ≤40=2, 40-60=3, \>60=4), sex (male=0; female=1), body mass index (BMI), and indoor and outdoor temperature. Change over time was incorporated by inclusion of baseline values in the model.

We carried out various sensitivity analyses to examine the robustness of the conclusions of the primary analysis. We performed an analysis based on intention to treat but excluded possibly incomplete 24 hour urine collections defined as urine volume \<500 mL/24 hour or creatinine \<4.0 mmol/24 hour (women) or \<6.0 mmol/24 hour (men)[@ref25] for adults and \<300 mL/24 hour[@ref26] or creatinine \<5th centile (that is, \<2.5 mmol/24 hour for girls and \<2.9 mmol/24 hour for boys) for children. From a total of 3268 urine collections, we excluded 225. If one of the two 24 hour urine collections was incomplete, we used only one in the sensitivity analysis. We also carried out an analysis including only participants who completed both baseline and end trial assessments (named as "completers") and a per protocol analysis that included completers with complete 24 hour urine collections (that is, excluding possibly incomplete 24 hour urine collections).

We used SAS (version 9.4) for the analyses. Results are reported as mean, SD, SE, and 95% confidence interval when appropriate. All analyses were two sided, and P\<0.05 was considered significant.

Results
=======

We recruited 28 schools with 28 classes into the study. From 548 children who met the inclusion criteria for assessments, we randomly selected 357. From these children's families, we invited 713 adults. Of those recruited, 279 children and 553 adults completed the baseline assessments. During the trial, five children (1.8%) and 21 adults (3.8%) were lost to follow-up. Figure 1 shows the number of individuals by group and the reasons for loss to follow-up[](#fig1){ref-type="fig"}. There was no significant difference between the participants who were lost to follow-up and those who completed the study in age, sex, salt intake, or blood pressure in children or adults (data not shown). BMI, however, was higher in children who were lost to follow-up (22.0 *v* 16.8, P\<0.001).

![**Fig 1** Trial profile of school based education programme to reduce salt intake in children and their families](hefe023060.f1_default){#fig1}

Table 1[](#tbl1){ref-type="table"} shows the baseline characteristics of the participants. The mean age was 10.1 for children and 43.8 for adults. The two groups were well balanced in most parameters except for self reported hypertension, which was slightly higher in the intervention group.

###### 

 Baseline characteristics of participants in study of school based education programme to reduce salt intake in children and their families\*. Figures are numbers (percentage) unless stated otherwise

                                          Control (no salt education)   Intervention (salt education)   All
  --------------------------------------- ----------------------------- ------------------------------- -----------------
  **Cluster level**                                                                                     
   Schools                                14                            14                              28
   Median (range) No of children/school   10 (9-10)                     10 (10-11)                      10 (9-11)
   Median (range) No of adults/school     20 (17-20)                    20 (19-20)                      20 (17-20)
   Median (range) No of adults/family     2 (1-2)                       2 (1-2)                         2 (1-2)
  **Individual level**                                                                                  
  Total participants                      413                           419                             832
  Children:                                                                                             
   Total (No, % boys)                     138 (67, 48.6)                141 (67, 47.5)                  279 (134, 48.0)
   Mean (SD) age (year)                   10.2 (0.5)                    10.0 (0.5)                      10.1 (0.5)
   Mean (SD) weight (kg)                  33.3 (7.2)                    33.4 (7.8)                      33.3 (7.5)
   Mean (SD) height (cm)                  140.7 (6.6)                   139.2 (6.2)                     140.0 (6.5)
   Mean (SD) BMI                          16.7 (2.7)                    17.1 (3.2)                      16.9 (3.0)
  Adults:                                                                                               
   Total (No, % men)                      275 (133, 48.4)               278 (135, 48.6)                 553 (268, 48.5)
   Parents                                208 (75.6)                    203 (73.0)                      411 (74.3)
   Grandparents                           67 (24.4)                     75 (27.0)                       142 (25.7)
   Mean (SD) age (year)                   43.6 (11.8)                   43.9 (12.5)                     43.8 (12.2)
   Mean (SD) weight (kg)                  66.2 (12.9)                   66.1 (11.6)                     66.2 (12.3)
   Mean (SD) Height (cm)                  162.8 (8.7)                   162.4 (8.0)                     162.6 (8.4)
   Mean (SD) BMI                          24.9 (3.6)                    25.0 (3.4)                      24.9 (3.5)
   Education:                                                                                           
    ≤6 year                               55 (20.0)                     59 (21.2)                       114 (20.6)
    6-9 year                              132 (48.0)                    137 (49.3)                      269 (48.6)
    \>9 year                              88 (32.0)                     82 (29.5)                       170 (30.7)
   Alcohol drinkers                       101 (36.7)                    84 (30.2)                       185 (33.5)
   Smokers                                79 (28.7)                     76 (27.3)                       155 (28.0)
   Self reported hypertension             33 (12.0)                     42 (15.1)                       75 (13.6)
   BP treatment in hypertensives          28 (84.8)                     36 (85.7)                       64 (85.3)

BMI=body mass index; BP=blood pressure.

In the intervention group the average amount of salt used as measured by weighing showed an immediate and large decrease within the first two weeks of the intervention. From week two to four, there was a small fluctuation, and then a gradual and sustained reduction throughout the whole duration of the study (fig 2[](#fig2){ref-type="fig"}).

![**Fig 2** Amount of salt used in intervention group according to weight of salt containers](hefe023060.f2_default){#fig2}

Table 2[](#tbl2){ref-type="table"} shows the primary and secondary outcomes and other 24 hour urinary measurements. For all participants together, the mean baseline salt intake, as calculated from 24 hour urinary sodium, was 9.8 (SE 0.3) g/day in the control group and 10.8 (SE 0.3) g/day in the intervention group. During the study, salt intake increased in the control group and decreased in the intervention group. Therefore, the mean effect comparing the intervention with the control group was −2.6 g/day (95% confidence interval −3.2 to −2.0; P\<0.001), representing a 26% reduction. Systolic and diastolic blood pressure showed an increase from baseline to the end of the trial in both groups, but to a lesser extent in the intervention group. The mean effect was that, compared with the control, the intervention group had smaller rise in systolic blood pressure (−1.8 mm Hg (−3.4 to −0.1), P\<0.05). The difference in diastolic blood pressure was not significant (table 2[](#tbl2){ref-type="table"}).

###### 

 Salt intake as calculated from 24 hour urinary sodium, other urinary measurements, and blood pressure based on intention to treat analysis in study of school based education programme to reduce salt intake in children and their families

                                  Control (no salt education)                 Intervention (salt education)   Adjusted difference† (intervention *v* control) (95% CI), P value                                                        
  ------------------------------- ----------------------------- ------------- ------------------------------- ------------------------------------------------------------------- ------------- ------------- ------------------------ ---------------------------------
  **All participants**                                                                                                                                                                                                                 
  Urine volume (mL/24h)           1337 (47)                     1475 (48)     138 (89 to 188)                                                                                     1376 (47)     1411 (47)     35 (−14 to 83)           −99 (−169 to −30), 0.005
  Urinary sodium (mmol/24h)       167.6 (5.7)                   183.1 (5.7)   15.5 (8.7 to 22.3)                                                                                  184.3 (5.7)   155.9 (5.7)   −28.5 (−35.2 to −21.8)   −44.4 (−53.9 to −34.9), \<0.001
  Salt (g/d)                      9.8 (0.3)                     10.7 (0.3)    0.9 (0.5 to 1.3)                                                                                    10.8 (0.3)    9.1 (0.3)     −1.7 (−2.1 to −1.3)      −2.6 (−3.2 to −2.0), \<0.001
  Urinary potassium (mmol/24h)    32.5 (0.9)                    33.9 (0.9)    1.4 (−0.04 to 2.8)                                                                                  31.8 (0.9)    33.7 (0.9)    2.0 (0.6 to 3.3)         0.6 (−1.4 to 2.5), 0.59
  Urinary creatinine (mmol/24h)   7.8 (0.2)                     7.8 (0.2)     0.1 (−0.1 to 0.2)                                                                                   7.9 (0.2)     7.8 (0.2)     −0.1 (−0.3 to 0.03)      −0.2 (−0.5 to 0.04), 0.10
  Systolic BP (mm Hg)             118.1 (1.2)                   122.9 (1.2)   4.8 (3.6 to 6.0)                                                                                    120.1 (1.2)   123.6 (1.2)   3.5 (2.3 to 4.7)         −1.8 (−3.4 to −0.1), \<0.04
  Diastolic BP (mm Hg)            75.5 (0.9)                    78.8 (1.0)    3.3 (2.3 to 4.4)                                                                                    76.5 (0.9)    79.1 (0.9)    2.6 (1.6 to 3.6)         −1.1 (−2.5 to 0.4), 0.15
  **Children**                                                                                                                                                                                                                         
  Urine volume (mL/24h)           862 (38)                      952 (38)      90 (35 to 145)                                                                                      867 (37)      831 (38)      −37 (−91 to 18)          −124 (−201 to −46), 0.002
  Urinary sodium (mmol/24h)       116.7 (5.2)                   137.2 (5.2)   20.5 (12.6 to 28.4)                                                                                 124.2 (5.1)   112.2 (5.1)   −12.1 (−19.9 to −4.2)    −33.3 (−44.2 to −22.3), \<0.001
  Salt (g/d)                      6.8 (0.3)                     8.0 (0.3)     1.2 (0.7 to 1.7)                                                                                    7.3 (0.3)     6.6 (0.3)     −0.7 (−1.2 to −0.2)      −1.9 (−2.6 to −1.3), \<0.001
  Urinary potassium (mmol/24h)    25.4 (0.9)                    25.9 (0.9)    0.5 (−1.2 to 2.3)                                                                                   23.5 (0.9)    25.3 (0.9)    1.8 (0.1 to 3.5)         1.3 (−1.1 to 3.8), 0.28
  Urinary creatinine (mmol/24h)   4.9 (0.2)                     5.2 (0.2)     0.4 (0.2 to 0.5)                                                                                    4.7 (0.2)     5.1 (0.2)     0.4 (0.2 to 0.5)         −0.006 (−0.2 to 0.2), 0.96
  Systolic BP (mm Hg)             106.2 (1.0)                   110.6 (1.0)   4.4 (2.8 to 6.0)                                                                                    106.2 (1.0)   110.0 (1.0)   3.8 (2.3 to 5.4)         −0.8 (−3.0 to 1.5), 0.51
  Diastolic BP (mm Hg)            66.8 (1.1)                    70.2 (1.1)    3.4 (1.6 to 5.1)                                                                                    67.0 (1.1)    69.4 (1.1)    2.4 (0.7 to 4.1)         −1.2 (−3.7 to 1.2), 0.33
  **Adults**                                                                                                                                                                                                                           
  Urine volume (mL/24h)           1577 (61)                     1740 (62)     163 (94 to 232)                                                                                     1636 (61)     1709 (61)     73 (5 to 141)            −86 (−183 to 10), 0.08
  Urinary sodium (mmol/24h)       193.4 (6.7)                   206.6 (6.8)   13.2 (3.8 to 22.6)                                                                                  215.1 (6.7)   178.5 (6.7)   −36.6 (−45.8 to −27.3)   −50.0 (−63.1 to −36.8), \<0.001
  Salt (g/d)                      11.3 (0.4)                    12.1 (0.4)    0.8 (0.2 to 1.3)                                                                                    12.6 (0.4)    10.4 (0.4)    −2.1 (−2.7 to −1.6)      −2.9 (−3.7 to −2.2), \<0.001
  Urinary potassium (mmol/24h)    36.1 (1.0)                    38.0 (1.0)    1.9 (−0.1 to 3.8)                                                                                   36.0 (1.0)    38.1 (1.0)    2.1 (0.2 to 4.0)         0.1 (−2.6 to 2.9), 0.93
  Urinary creatinine (mmol/24h)   9.3 (0.2)                     9.2 (0.2)     −0.1 (−0.4 to 0.1)                                                                                  9.5 (0.2)     9.1 (0.2)     −0.4 (−0.7 to −0.2)      −0.3 (−0.6 to 0.04), 0.09
  Systolic BP (mm Hg)             124.1 (1.5)                   129.1 (1.5)   5.0 (3.4 to 6.6)                                                                                    127.1 (1.5)   130.5 (1.5)   3.4 (1.8 to 4.9)         −2.3 (−4.5 to −0.04), \<0.05
  Diastolic BP (mm Hg)            79.9 (1.0)                    83.2 (1.1)    3.3 (2.0 to 4.6)                                                                                    81.4 (1.0)    84.1 (1.0)    2.8 (1.5 to 4.0)         −0.9 (−2.8 to 0.9), 0.31

BP=blood pressure.

\*Adjusted for stratification variables at randomisation (school location and class size).

†Adjusted for age, sex, BMI, stratification variables at randomisation (school location and class size), and indoor and outdoor temperature.

In children, the mean baseline salt intake was 6.8 (SE 0.3) g/day in the control group and 7.3 (SE 0.3) g/day in the intervention group. The mean effect size after the intervention was −1.9 g/day (95% confidence interval −2.6 to −1.3 g/day; P\<0.001), representing a 27% reduction compared with the control group. The effect on blood pressure was not significant (table 2[](#tbl2){ref-type="table"}).

In adults, the mean baseline salt intake was 11.3 (SE 0.4) g/day and 12.6 (SE 0.4) g/day for the control and intervention groups, respectively. The mean effect size after the intervention was −2.9 g/day (95% confidence interval −3.7 to −2.2 g/day; P\<0.001), representing a 25% reduction compared with the control. The mean effect on systolic blood pressure was −2.3 mm Hg (−4.5 to −0.04 mm Hg), P\<0.05). The effect on diastolic blood pressure was not significant.

Table 3[](#tbl3){ref-type="table"} shows the results from sensitivity analyses. The first analysis excluded possibly incomplete 24 urine collections. As expected, the absolute levels of salt intake were higher than those when we included all 24 hour urine collections. The primary outcome, however---that is, the difference between the two groups in the change of salt intake---was similar to that from the main analysis. The results for completers and per protocol analyses were close to those from the corresponding analyses with all participants included.

###### 

 Sensitivity analysis for salt intake (g/day) as calculated from 24 hour urinary sodium

                                                        No in control/intervention   Control                         Intervention   Adjusted difference† (intervention *v* control) (95% CI), P value                         
  ----------------------------------------------------- ---------------------------- ------------ ------------------ -------------- ------------------------------------------------------------------- --------------------- ------------------------------
  Population excluding possible incomplete 24h urine:                                                                                                                                                                         
   All                                                  411/415                      10.0 (0.3)   0.9 (0.6 to 1.3)                  11.0 (0.3)                                                          −1.6 (−2.0 to −1.2)   −2.6 (−3.1 to −2.1), \<0.001
   Children                                             138/140                      7.0 (0.3)    1.2 (0.7 to 1.6)                  7.5 (0.3)                                                           −0.7 (−1.1 to −0.2)   −1.9 (−2.6 to −1.2), \<0.001
   Adults                                               273/275                      11.6 (0.4)   0.8 (0.3 to 1.4)                  12.8 (0.4)                                                          −2.1 (−2.6 to −1.6)   −3.0 (−3.7 to −2.2), \<0.001
  Completers‡:                                                                                                                                                                                                                
   All                                                  396/410                      9.8 (0.3)    0.9 (0.5 to 1.3)                  10.8 (0.3)                                                          −1.7 (−2.1 to −1.3)   −2.6 (−3.2 to −2.1), \<0.001
   Children                                             135/139                      6.8 (0.3)    1.2 (0.8 to 1.7)                  7.2 (0.3)                                                           −0.7 (−1.2 to −0.2)   −1.9 (−2.6 to −1.3), \<0.001
   Adults                                               261/271                      11.4 (0.4)   0.8 (0.2 to 1.3)                  12.7 (0.4)                                                          −2.2 (−2.7 to −1.6)   −3.0 (−3.7 to −2.2), \<0.001
  Per protocol population§:                                                                                                                                                                                                   
   All                                                  381/393                      10.0 (0.3)   1.0 (0.6 to 1.4)                  11.0 (0.3)                                                          −1.6 (−2.0 to −1.2)   −2.6 (−3.2 to −2.1), \<0.001
   Children                                             132/137                      7.0 (0.3)    1.2 (0.7 to 1.7)                  7.5 (0.3)                                                           −0.7 (−1.1 to −0.2)   −1.9 (−2.6 to −1.3), \<0.001
   Adults                                               249/256                      11.6 (0.4)   0.9 (0.3 to 1.4)                  12.9 (0.4)                                                          −2.1 (−2.6 to −1.6)   −3.0 (−3.7 to −2.3), \<0.001

**\***Adjusted for stratification variables at randomisation (school location and class size).

†Adjusted for age, sex, body mass index, stratification variables at randomisation (school location and class size), and indoor and outdoor temperature.

‡Participants with 24 hour urine collections at baseline and end of trial.

§Completers with complete 24 hour urine collections.

From baseline to the end of the trial there was a large fall in ambient temperature. In the control group the mean outdoor temperature fell from 26.1°C to 2.3°C and the mean indoor temperature fell from 25.5°C to 15.8°C; in the intervention group the figures were from 26.1°C to 1.1°C and from 25.5°C to 15.4°C, respectively.

Discussion
==========

The School-EduSalt trial is the first to explore the use of a primary school setting to educate children on salt reduction and to empower children to deliver the message to their families. On average, salt intake was reduced by 1.9 g/day (27%) in children and 2.9 g/day (25%) in adults over a period of one school term of about 3.5 months. This reduction in salt intake was accompanied by a significant fall in systolic blood pressure in adults. These findings show that the School-EduSalt approach is feasible and effective in lowering salt intake in both children and their families.

Salt intake
-----------

We used repeat 24 hour urine collections (the most accurate method) to measure salt intake in a large number of primary school children in northern China and showed that the intake was high. A conservative estimate indicated that the average salt intake at baseline was 7.0 g/day for children aged 10, which is 40% higher than the WHO recommended level of 5 g/day for adults. We also found a high current salt intake in the adult family members, with an average baseline intake of 11.7 g/day, which is more than double the WHO recommended level.

We weighed the amount of salt used by the family every two weeks and showed a sustained reduction over the study period. Despite this, we focused on the urinary data because the dietary method is known to be unreliable in estimating salt intake---for example, some of the salt was used for soaking eggs rather than consumed. We collected two 24 hour urine samples at each time point, and the collections were carefully supervised with both the start and finish time recorded by trained research staff. We are sure that there was no over-collection, however, it is difficult to know whether there was any under-collection. Although the participants who admitted having missed urine voids were asked to do another 24 hour urine collection, it is still possible that some participants did not report missing urine collection. Exclusion of potentially incomplete collections, as expected, led to a slightly higher mean salt intake for both baseline and the end of the trial and for both the intervention and control groups. It is therefore likely that our main results have underestimated the average salt intake of the study population. This is unlikely to alter the primary outcome---that is, the difference between the intervention and control group. Indeed, various sensitivity analyses showed consistent findings (table 3[](#tbl3){ref-type="table"}).

Comparison with other studies
-----------------------------

Our baseline finding of a high salt intake in adults is consistent with the findings of several recent studies in northern China, where salt intake estimated from 24 hour urinary sodium, ranged from 11.8 g/day to 13.9 g/day.[@ref20] [@ref27] [@ref28] The variations between studies could be attributable to differences in geographical regions, study populations, seasons when the study was carried out, and criteria used to assess over-collection and under-collection.

During our study, the control group showed an increase in salt intake. This is probably because of seasonal influence as our baseline assessments were carried out in summer and the follow-up was in winter. Salt intake in northern China is usually higher in winter because people eat more pickles because of reduced availability of fresh vegetables.

Many previous studies have reported seasonal variations in blood pressure.[@ref29] A large study involving over 500 000 adults from 10 geographically diverse regions of China over a four year period showed a strong inverse association between blood pressure and outdoor temperature, with 5.7 mm Hg higher systolic blood pressure per 10°C lower temperature. In our study, we observed a large fall in both indoor and outdoor temperature from baseline to the end of the trial. This could explain the increase in blood pressure observed in our study, though the rise in blood pressure was significantly smaller in the intervention group than in the control group, because of salt reduction.

Previous meta-analysis of randomised trials on salt reduction showed that a 1 g/day reduction in salt intake led to about a 1 mm Hg reduction in systolic blood pressure.[@ref5] It has also been shown that, for a given reduction in salt intake, the fall in blood pressure was larger in older people than younger individuals and larger in those with than without hypertension.[@ref5] Our current study showed a 2.3 mm Hg reduction in systolic blood pressure with a 2.9 g/day reduction in salt intake in adults. Given that our adult participants were relatively young, with a mean age of 44, and predominately normotensive, it is therefore not surprising that the fall in systolic blood pressure was slightly smaller than that found in the meta-analysis of salt reduction trials. Our study also showed that in children, a reduction of 1.9 g/day (27%) in salt intake was related to a fall in blood pressure of 0.8/1.2 mm Hg. Although this is not significant, the magnitude of the fall in blood pressure is similar to that predicted from a meta-analysis of salt reduction trials in children.[@ref16]

Public health implications
--------------------------

It is well established that blood pressure throughout its range starting from 115/75 mm Hg is a major cause of cardiovascular disease.[@ref30] A reduction in salt intake through its effect on blood pressure should reduce the risk of cardiovascular disease. Based on the meta-analysis of trials on treatment of blood pressure,[@ref31] we estimated that a 2.3 mm Hg reduction in systolic blood pressure that occurred with salt reduction would reduce incidence of stroke by about 9% and ischaemic heart disease by about 5%. In China this could prevent about 153 000 deaths from strokes and about 47 000 deaths from ischaemic heart disease a year.

Our findings have major public health implications. China, like many other developing countries, is experiencing fast epidemiological transition with a rapid increase in the disease burden attributed to blood pressure.[@ref32] Traditionally, prevention and control of hypertension have been managed within the healthcare system.[@ref33] In China and other developing countries, however, the health services are less developed with little capacity for prevention. The School-EduSalt offers a novel approach to preventing diseases related to raised blood pressure by reducing population salt intake. This approach has several advantages. Because universal primary education is a common goal in most national education policies, the School-EduSalt approach is likely to have a greater impact on preventing hypertension than the traditional way of using the healthcare system. Conveying a salt reduction message to children has the potential to set habits and attitudes that will persist throughout adulthood. Furthermore, the School-EduSalt approach reaches a wide range of the population from children to adults and therefore has the potential to achieve a large impact.

It is important to emphasise that to achieve the greatest reduction in population salt intake, the School-EduSalt approach should be combined with other strategies, which were not included in our study. For example, in children who have meals in schools, a reduction in the salt content will help reduce children's salt intake further. Additionally, there has been an increasing trend in the consumption of processed foods in China.[@ref34] It is therefore also important to work with the food industry to gradually reduce the amount of salt added to all processed foods, as is occurring successfully in the United Kingdom, with an accompanying fall in population blood pressure and mortality from cardiovascular disease.[@ref8] [@ref35]

Conclusions
-----------

Our study shows that, in northern China, salt intake as measured by 24 hour urinary sodium is high in both children and adults. An education programme targeted at primary school children is effective in lowering salt intake in children and their families. These results should be broadly applicable to most schools in China as our intervention programme was delivered using the usual health education lessons as in the national school curriculum. A nationwide implementation of the education programme could have a large impact on reducing population salt intake in China and morbidity and mortality from cardiovascular disease.

### What is already known on this topic

1.  Salt intake is high in China, and salt is added mainly by the consumers. Salt reduction is one of the most cost effective measures to reduce the disease burden related to raised blood pressure

2.  There have been no successful salt reduction programmes in countries where most of the salt in the diet is added by consumers. Furthermore, it is not clear whether an education programme targeted at primary school children could lower salt intake in children and their families

### What this study adds

1.  A reduction in salt intake can be achieved by integrating salt reduction education modules into primary school curriculums and empowering children to deliver the salt reduction message to their families

2.  This is a novel, feasible, and effective approach to reducing salt intake in a population in which most of the salt in the diet is added by consumers

3.  Our findings suggest that the WHO's target of 30% reduction in salt intake by 2025 could be achieved in China if the education programme was implemented nationwide and could result in a major reduction in cardiovascular morbidity and mortality
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